Decoy Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -8,516 | -1 | -1 |
EBITDA | -9,059 | -872 | -964 |
EBIT | -9,056 | -873 | -965 |
Net Income | -8,977 | -873 | -957 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -1,136 | -1,646 | -862 |
Cash | 10,709 | 4,809 | 794 |
Basic Shares | 481 | 481 | 142 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -8,517 | -4 | -10 | -6 |
EBITDA | -12,613 | -5,729 | -12,884 | -22,968 |
EBIT | -5,734 | -12,894 | -22,975 | |
Net Income | -12,518 | -5,575 | -12,542 | -31,607 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,827 | -4,525 | -12,846 | -19,095 |
Cash | 10,709 | 2,434 | 5,899 | 12,106 |
Basic Shares | 481 | 64 | 34 | 18 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$4.18 |
2025-12-31 | $43.10 |
2025-09-30 | -$1.81 |
2025-06-30 | -$0.45 |